Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma

Clinical trial NCT06627244 · RECRUITING

Trial details

NCT number: NCT06627244
Sponsor: University of Miami
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Uveal Melanoma Metastatic Uveal Melanoma in the Liver

Start date: 2025-02-14
Primary completion: 2028-02-17
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.